FR2362629A1 - Composition pharmaceutique a base de pirbuterol et d'hydroxyzine - Google Patents

Composition pharmaceutique a base de pirbuterol et d'hydroxyzine

Info

Publication number
FR2362629A1
FR2362629A1 FR7725959A FR7725959A FR2362629A1 FR 2362629 A1 FR2362629 A1 FR 2362629A1 FR 7725959 A FR7725959 A FR 7725959A FR 7725959 A FR7725959 A FR 7725959A FR 2362629 A1 FR2362629 A1 FR 2362629A1
Authority
FR
France
Prior art keywords
pirbuterol
hydroxyzine
pharmaceutical composition
composition based
bronchodilators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7725959A
Other languages
English (en)
French (fr)
Other versions
FR2362629B1 (cs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of FR2362629A1 publication Critical patent/FR2362629A1/fr
Application granted granted Critical
Publication of FR2362629B1 publication Critical patent/FR2362629B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7725959A 1976-08-26 1977-08-25 Composition pharmaceutique a base de pirbuterol et d'hydroxyzine Granted FR2362629A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71790576A 1976-08-26 1976-08-26

Publications (2)

Publication Number Publication Date
FR2362629A1 true FR2362629A1 (fr) 1978-03-24
FR2362629B1 FR2362629B1 (cs) 1980-07-11

Family

ID=24883964

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7725959A Granted FR2362629A1 (fr) 1976-08-26 1977-08-25 Composition pharmaceutique a base de pirbuterol et d'hydroxyzine

Country Status (19)

Country Link
JP (1) JPS5329935A (cs)
AU (1) AU503877B2 (cs)
BE (1) BE858094A (cs)
CA (1) CA1092028A (cs)
DE (1) DE2737735C3 (cs)
DK (1) DK354377A (cs)
FR (1) FR2362629A1 (cs)
GB (1) GB1541991A (cs)
GR (1) GR68687B (cs)
HK (1) HK30981A (cs)
IE (1) IE45768B1 (cs)
IL (1) IL52588A (cs)
LU (1) LU78022A1 (cs)
MY (1) MY8100263A (cs)
NL (1) NL170367C (cs)
NZ (1) NZ184746A (cs)
PT (1) PT66866B (cs)
SE (1) SE7708307L (cs)
ZA (1) ZA774474B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63156327U (cs) * 1987-04-02 1988-10-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899436A (en) * 1959-08-11 chjch
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators

Also Published As

Publication number Publication date
DE2737735B2 (de) 1979-03-08
PT66866B (en) 1978-12-29
FR2362629B1 (cs) 1980-07-11
NZ184746A (en) 1980-02-21
NL7708732A (nl) 1978-02-28
DK354377A (da) 1978-02-27
IL52588A (en) 1980-07-31
ZA774474B (en) 1978-06-28
DE2737735A1 (de) 1978-03-02
IE45768B1 (en) 1982-11-17
DE2737735C3 (de) 1979-10-25
AU2741277A (en) 1979-02-01
NL170367C (nl) 1982-11-01
LU78022A1 (fr) 1979-05-23
CA1092028A (en) 1980-12-23
MY8100263A (en) 1981-12-31
IE45768L (en) 1978-02-28
BE858094A (fr) 1978-02-27
AU503877B2 (en) 1979-09-27
JPS5329935A (en) 1978-03-20
GB1541991A (en) 1979-03-14
HK30981A (en) 1981-07-10
SE7708307L (sv) 1978-02-27
PT66866A (en) 1977-08-01
IL52588A0 (en) 1977-10-31
GR68687B (cs) 1982-02-01

Similar Documents

Publication Publication Date Title
MY101207A (en) Treatment of diseases caused by retroviruses
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
CA2166898A1 (en) Novel structural analogues of vitamin d
HUP0004040A1 (hu) Antimikrobiális hatású pleuromutilinszármazékok, eljárás ezek előállítására, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
GR3007251T3 (cs)
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
ES2163425T3 (es) Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica.
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
GB1310658A (en) Composition and method for treatment of hepatic disease and mental fatugue
KR880007514A (ko) 키놀린 화합물
MY111055A (en) Pharmaceutical composition and process for the preparation thereof
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
EP1069125A3 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
FR2362629A1 (fr) Composition pharmaceutique a base de pirbuterol et d'hydroxyzine
BE900959A (fr) Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.
EP0150710A3 (en) 7-oxabicycloheptane prostaglandin analogs
KR890012942A (ko) 5-치환된 오르니틴 유도체
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
GR3001420T3 (en) Prazosin-pirbuterol combination for bronchodilation
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
CA2181225A1 (en) The use of sertraline to treat post myocardial infarction patients
ES419381A1 (es) Un procedimiento para la preparacion de nuevos derivados de2-amino (1,2,3,4-tetrahidronaftaleno).